Downloads: 11

Files in This Item:
File Description SizeFormat 
j.bjps.2024.08.058.pdf4.72 MBAdobe PDFView/Open
Title: Additional treatments after curettage of congenital melanocytic nevi in the craniofacial region: Areport from a single center in Japan.
Authors: Masuno, Haruko
Sakamoto, Michiharu
Katayama, Yasuhiro
Yamanaka, Hiroki
Tsuge, Itaru
Katsube, Motoki
Saito, Susumu
Morimoto, Naoki
Author's alias: 増野, 晴子
坂本, 道治
片山, 泰博
山中, 浩気
津下, 到
勝部, 元紀
齊藤, 晋
森本, 尚樹
Keywords: Congenital melanocytic nevus
Craniofacial
Curettage
Cultured epithelial autograft
Reconstruction
Laser treatment
Issue Date: Nov-2024
Publisher: Elsevier Ltd
Journal title: Journal of Plastic, Reconstructive & Aesthetic Surgery
Volume: 98
Start page: 122
End page: 130
Abstract: Background: Congenital melanocytic nevus (CMN) is a benign skin lesion present from birth, which may present with a risk of malignant transformation if extensive. Curettage, a treatment method involving the removal of the superficial layer of the nevus, is often used in the early stages of life. However, recurrence of the nevus and postoperative scarring may present as problems. Additional treatments, such as resection and/or laser treatment, are regularly required after curettage, particularly in the craniofacial region. However, no systematic treatment strategy has been reported. This study investigated additional treatments used after curettage to treat CMN in the craniofacial region and compared the frequency of treatments with respect to specific sites. Methods: CMN cases involving curettage as an initial treatment were retrospectively reviewed at Kyoto University Hospital between May 2019 and April 2022. Results: This study comprised 23 cases. Curettage was performed at a mean of 3.8 (1-10) months of age. No additional treatments were provided for 80% of head CMN. Additional treatments were performed in all cases, including the forehead and cheek. Laser treatment was performed in 86% of eyelid CMN and 75% of nasal CMN. Tissue expansion and flap closure were used in 33% of forehead CMN and 33% of cheek CMN. Conclusions: Additional treatments used for CMN in the craniofacial region varied in accordance with the lesion site.
Rights: © 2024 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license.
URI: http://hdl.handle.net/2433/290112
DOI(Published Version): 10.1016/j.bjps.2024.08.058
PubMed ID: 39243714
Appears in Collections:Journal Articles

Show full item record

Export to RefWorks


Export Format: 


This item is licensed under a Creative Commons License Creative Commons